NCT07747896

Brief Summary

The TSS project is a study of the effects of treating hard-to-heal ulcers in a multidisciplinary cross sectional team, meaning that nurse and doctor from a hospital based wound healing clinic and wound care nurse from the primary care sector treat the patient in collaboration rather than the current form where care in municipalities and hospital setting, communicate but treat the patient on their own. The study is designed as a randomized study, meaning that individuals with hard-to-heal ulcers are randomly designated to standard care or the multidis-ciplinary team. We measure several aspects of the new format, but the main outcome com-pared between the two groups (standard care and multidisciplinary care) is number of ulcers healed. Participants are followed for a year after inclusion in the study, and have 6 fixed visits in the clinic, with the possibility of more visits if necessary. There is no "new" medicine, surgery or other treatments planned in the study, but the multi-disciplinary team can offer and implement any treatment deemed appropriate for the individ-ual that is allocated to the multidisciplinary team, of course the individual has the opportunity to decline any treatment offered by the team. The control group, i.e. individuals allocated to standard care, will receive the treatment that is normally available to individuals with hard-to-heal ulcers treated in the municipality, including referral to hospital based treatments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Aug 2026Oct 2028

First Submitted

Initial submission to the registry

July 9, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2028

Last Updated

August 5, 2026

Status Verified

July 1, 2026

Enrollment Period

9 months

First QC Date

July 9, 2026

Last Update Submit

August 4, 2026

Conditions

Keywords

Diabetic Foot UlcerMDTHard-to-heal ulcerCross Sectional Collaboration

Outcome Measures

Primary Outcomes (1)

  • Ulcer healing

    Number of individuals that achieve healing of their hard-to-heal ulcer(s), compared between two arms

    Ulcer healing at 12 months

Secondary Outcomes (13)

  • Time to ulcer healing

    12 moths

  • Ulcer recurrence

    12 months

  • Infections

    12 months

  • Amputations

    12 months

  • Visits

    12 months

  • +8 more secondary outcomes

Study Arms (2)

coordinated primary-care-based MDT-model

EXPERIMENTAL

The proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing, the participant is pla

Other: coordinated primary-care-based MDT-model

Standard Care

ACTIVE COMPARATOR

Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.

Other: Standard Care (in control arm)

Interventions

The proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following

coordinated primary-care-based MDT-model

Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.

Standard Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or above
  • Hard-to-heal ulcer(s)
  • Able to understand written and oral information
  • Ability to follow planned visits and treatment
  • Able to provide informed consent in Danish and/or English

You may not qualify if:

  • Revascularization procedure in the affected limb planned, or undertaken within the 4 weeks prior to screening
  • Toe blood pressure \< 35mmHg
  • Infections of the ulcer needing acute or sub-acute (defined as within seven days) surgical treatment
  • Prior major amputations on affected or contralateral leg
  • Current treatment with cytotoxic drugs or with systemically administered glucocorticoids
  • Likely inability to comply with the need for planned visits because of planned activities
  • Participation in another interventional ulcer-healing trial within the 4 weeks prior to screening
  • Prior enrolment in this trial
  • Judgement by the investigator that the patient does not have the capacity to understand the study procedures or provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Zealand Hospital

Hillerød, 3400, Denmark

RECRUITING

MeSH Terms

Conditions

Diabetic FootUlcer

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic NeuropathiesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Jonas Askø Andersen, Md Phd Clin Assoc Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Phd Clin Assoc Prof

Study Record Dates

First Submitted

July 9, 2026

First Posted

August 5, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

October 31, 2028

Last Updated

August 5, 2026

Record last verified: 2026-07

Locations